<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="128273">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01432275</url>
  </required_header>
  <id_info>
    <org_study_id>ADC-PMS-INX-11011</org_study_id>
    <nct_id>NCT01432275</nct_id>
  </id_info>
  <brief_title>Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home Study</brief_title>
  <acronym>IHUT</acronym>
  <official_title>Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Diabetes Care</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Diabetes Care</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate user preference and ease of use of the FreeStyle
      InsuLinx system, compared to current methodology, when used at home by subjects with
      diabetes.

      Subjects will also be comparing the ease of use of the FreeStyle InsuLinx system with
      comparator meters.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>User preference compared to current method</measure>
    <time_frame>25 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>User preference against comparison meters</measure>
    <time_frame>25 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">179</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Comparator, ADC, ADC with calculator</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subject uses comparator blood glucose meter for 7 days, followed by the ADC blood glucose meter for 7 days with the insulin calculator not activated. For the last 10 days the subject uses the ADC blood glucose meter with insulin calculator activated for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADC, comparator, ADC with calculator</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subject the ADC blood glucose meter for 7 days with the insulin calculator not activated, followed by a comparator blood glucose meter for 7 days. For the last 10 days the subject uses the ADC blood glucose meter with insulin calculator activated for 10 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Self monitoring blood glucose system</intervention_name>
    <description>Use the comparator system for 7 days, then the InsuLinx system for 7 days in blood glucose mode only. Then 10 days using the InsuLinx system with insulin calculator.</description>
    <arm_group_label>Comparator, ADC, ADC with calculator</arm_group_label>
    <other_name>Abbott Freestyle InsuLinx</other_name>
    <other_name>Roche Accu-Chek Aviva Nano</other_name>
    <other_name>Lifescan Verio Pro</other_name>
    <other_name>Bayer Contour USB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Self monitoring blood glucose system</intervention_name>
    <description>Use the InsuLinx system for 7 days in blood glucose mode only, then use the comparator system for 7 days. Then 10 days using the InsuLinx with insulin calculator.</description>
    <arm_group_label>ADC, comparator, ADC with calculator</arm_group_label>
    <other_name>Freestyle InsuLinx</other_name>
    <other_name>Roche Accu-Chek Aviva Nano</other_name>
    <other_name>Lifescan Verio Pro or</other_name>
    <other_name>Bayer Contour USB</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject with Type 1 or 2 diabetes on a bolus regime (U100 insulin), one or more bolus
             injections per day for at least 6 months;

          -  Age 18 yrs and above;

          -  Regularly testing SMBG 3 or more times per day;

          -  Willingness to test at least 4 times per day.

        Exclusion Criteria:

          -  Know to require a bolus injection of more than 50U in a single dose;

          -  Has previously used either the InsuLinx or assigned comparison meter;

          -  Participated in structured diabetes management training in the last 6 months

          -  Is currently on an insulin pump;

          -  Has concomitant disease that, in the Investigator's opinion, may compromise patient
             safety;

          -  Is participating in another study of a glucose monitoring device or drug that could
             affect glucose measurements or glucose management;

          -  Female subject who is pregnant or planning to become pregnant during the course of
             the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shenaz Ramtoola</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Blackburn Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tameside Hospital NHS Foundation Trust</name>
      <address>
        <city>Ashton-under-Lyne</city>
        <zip>OL6 9RW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ayr Hospital</name>
      <address>
        <city>Ayr</city>
        <zip>KA6 6DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal United Hospital</name>
      <address>
        <city>Bath</city>
        <zip>BA1 3NG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Blackburn Hospital</name>
      <address>
        <city>Blackburn</city>
        <zip>BB2 7PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Manchester Diabetes Centre</name>
      <address>
        <city>Crumpsall</city>
        <zip>M8 5RB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ipswich Hospital NHS Trust</name>
      <address>
        <city>Ipswich</city>
        <zip>IP4 5PD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenwood &amp; Sneinton Family Medical Centre</name>
      <address>
        <city>Nottingham</city>
        <zip>NG3 7DQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 10, 2012</lastchanged_date>
  <firstreceived_date>September 9, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>SMBG</keyword>
  <keyword>Insulin calculator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
